{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T10:11:14Z","timestamp":1782123074435,"version":"3.54.5"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T00:00:00Z","timestamp":1670544000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002839","name":"Charit\u00e9 - Universit\u00e4tsmedizin Berlin","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100002839","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Optic neuritis (ON) is a frequent presentation at onset\u00a0of multiple sclerosis (MS), neuromyelitis optica spectrum disorder (NMOSD), and myelin oligodendrocyte glycoprotein\u00a0antibody-associated disease (MOGAD). The pathophysiology underlying these diseases, especially MOGAD, is still being elucidated. While obesity has been reported to potentially be a risk factor for MS, this has not been explored in NMOSD or MOGAD. We aimed to investigate a possible association between obesity (body mass index [BMI]\u2009&gt;\u200930\u00a0kg\/m<jats:sup>2<\/jats:sup>) in\u00a0patients with MOGAD, aquaporin 4-IgG positive NMOSD (AQP4-IgG+\u2009NMOSD) or MS. In this\u00a0multicenter non-interventional retrospective study,\u00a0data was collected\u00a0from\u00a0patients with a first ever demyelinating attack of ON subsequently diagnosed with MOGAD (n\u2009=\u200944), AQP4-IgG+\u2009NMOSD (n\u2009=\u200949) or MS (n\u2009=\u200990) between 2005 and 2020. The following data was collected: age, sex, ethnicity, BMI (documented before corticosteroid treatment), and the\u00a0ON etiology after diagnostic work-up. A mixed model analysis was performed to assess the potential of obesity or BMI to predict MOGAD-ON, and to\u00a0distinguish MOGAD-ON from AQP4-IgG+\u2009NMOSD-ON and MS-ON. Main outcome measures included BMI in patients with acute ON and subsequent diagnosis of MOGAD, AQP4-IgG+\u2009NMOSD or MS. A higher BMI was significantly associated with a diagnosis of MOGAD-ON (<jats:italic>p<\/jats:italic>\u2009&lt;\u20090.001); in MOGAD patients the mean BMI was 31.6\u00a0kg\/m<jats:sup>2<\/jats:sup> (standard deviation (SD) 7.2), while the mean BMI was 24.7\u00a0kg\/m<jats:sup>2<\/jats:sup> (SD 5.3) in AQP4-IgG+\u2009NMOSD patients, and 26.9\u00a0kg\/m<jats:sup>2<\/jats:sup> (SD 6.2) in MS patients. Mixed-effects multinomial logistic regression, adjusted for age and sex, with obesity as a binary variable, revealed that obesity was associated with a higher odds ratio (OR) of a subsequent MOGAD diagnosis (OR 5.466, 95% CI [2.039, 14.650], <jats:italic>p<\/jats:italic>\u2009=\u20090.001) in contradistinction with AQP4-IgG+\u2009NMOSD. This study suggests an association between obesity and MOGAD. Our findings require further exploration, but could have significant pathophysiologic implications if confirmed in larger prospective studies.<\/jats:p>","DOI":"10.1038\/s41598-022-21592-8","type":"journal-article","created":{"date-parts":[[2022,12,9]],"date-time":"2022-12-09T10:03:36Z","timestamp":1670580216000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Obesity is associated with myelin oligodendrocyte glycoprotein antibody-associated disease in acute optic neuritis"],"prefix":"10.1038","volume":"12","author":[{"given":"Hadas","family":"Stiebel-Kalish","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Rubarth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karny","family":"Shouchane-Blum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alon","family":"Tiosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itay","family":"Lotan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adi","family":"Wilf-Yarkoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omer","family":"Bialer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eoin P.","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean J.","family":"Pittock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Tariq","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Schmitz-H\u00fcbsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedemann","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Asseyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,12,9]]},"reference":[{"issue":"10","key":"21592_CR1","doi-asserted-by":"publisher","first-page":"1628","DOI":"10.1016\/j.ophtha.2018.03.041","volume":"125","author":"J Jitprapaikulsan","year":"2018","unstructured":"Jitprapaikulsan, J. et al. Aquaporin-4 and myelin oligodendrocyte glycoprotein autoantibody status predict outcome of recurrent optic neuritis. Ophthalmology 125(10), 1628\u20131637 (2018).","journal-title":"Ophthalmology"},{"issue":"12","key":"21592_CR2","doi-asserted-by":"publisher","first-page":"3128","DOI":"10.1093\/brain\/awx276","volume":"140","author":"M Jurynczyk","year":"2017","unstructured":"Jurynczyk, M. et al. Clinical presentation and prognosis in MOG-antibody disease: a UK study. Brain 140(12), 3128\u20133138. https:\/\/doi.org\/10.1093\/brain\/awx276 (2017).","journal-title":"Brain"},{"issue":"2","key":"21592_CR3","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/ANA.25291","volume":"84","author":"M Spadaro","year":"2018","unstructured":"Spadaro, M. et al. Pathogenicity of human antibodies against myelin oligodendrocyte glycoprotein. Ann. Neurol. 84(2), 315\u2013328. https:\/\/doi.org\/10.1002\/ANA.25291 (2018).","journal-title":"Ann. Neurol."},{"key":"21592_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000012","author":"RC Dale","year":"2014","unstructured":"Dale, R. C. et al. Antibodies to MOG have a demyelination phenotype and affect oligodendrocyte cytoskeleton. Neurol. Neuroimmunol. NeuroInflamm. https:\/\/doi.org\/10.1212\/NXI.0000000000000012 (2014).","journal-title":"Neurol. Neuroimmunol. NeuroInflamm."},{"key":"21592_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/JOURNAL.PMED.1002053","author":"LE Mokry","year":"2016","unstructured":"Mokry, L. E. et al. Obesity and multiple sclerosis: a mendelian randomization study. PLoS Med. https:\/\/doi.org\/10.1371\/JOURNAL.PMED.1002053 (2016).","journal-title":"PLoS Med."},{"key":"21592_CR6","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4036232","author":"JDJ Guerrero-Garc\u00eda","year":"2016","unstructured":"Guerrero-Garc\u00eda, J. D. J. et al. Multiple sclerosis and obesity: possible roles of adipokines. Mediators Inflamm. https:\/\/doi.org\/10.1155\/2016\/4036232 (2016).","journal-title":"Mediators Inflamm."},{"issue":"7","key":"21592_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.29245\/2572.942X\/2016\/7.1064","volume":"1","author":"M Gianfrancesco","year":"2016","unstructured":"Gianfrancesco, M. & Barcellos, L. Obesity and multiple sclerosis susceptibility: a review. J. Neurol. Neuromed. 1(7), 1\u20135. https:\/\/doi.org\/10.29245\/2572.942X\/2016\/7.1064 (2016).","journal-title":"J. Neurol. Neuromed."},{"issue":"9","key":"21592_CR8","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1007\/s00415-018-8956-y","volume":"265","author":"I Lotan","year":"2018","unstructured":"Lotan, I. et al. Myelin oligodendrocyte glycoprotein-positive optic neuritis masquerading as pseudotumor cerebri at presentation. J. Neurol. 265(9), 1985\u20131988. https:\/\/doi.org\/10.1007\/s00415-018-8956-y (2018).","journal-title":"J. Neurol."},{"key":"21592_CR9","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/J.MSARD.2018.10.003","volume":"27","author":"RN Narayan","year":"2019","unstructured":"Narayan, R. N., Wang, C., Sguigna, P., Husari, K. & Greenberg, B. Atypical anti-MOG syndrome with aseptic meningoencephalitis and pseudotumor cerebri-like presentations. Mult. Scler. Relat. Disord. 27, 30\u201333. https:\/\/doi.org\/10.1016\/J.MSARD.2018.10.003 (2019).","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"10","key":"21592_CR10","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1007\/s00415-017-8615-8","volume":"264","author":"D Biotti","year":"2017","unstructured":"Biotti, D. et al. Optic neuritis in patients with anti-MOG antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France. J. Neurol. 264(10), 2173\u20132175. https:\/\/doi.org\/10.1007\/s00415-017-8615-8 (2017).","journal-title":"J. Neurol."},{"key":"21592_CR11","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson, A. J. et al. Diagnosis of multiple sclerosis\u202f: 2017 revisions of the McDonald criteria. Lancet Neurol. 17, 162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2 (2018).","journal-title":"Lancet Neurol."},{"key":"21592_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM Wingerchuk","year":"2015","unstructured":"Wingerchuk, D. M. et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology 85, 177\u2013189 (2015).","journal-title":"Neurology"},{"issue":"9","key":"21592_CR13","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/S1474-4422(21)00218-0","volume":"20","author":"R Marignier","year":"2021","unstructured":"Marignier, R. et al.  Myelin-oligodendrocyte glycoprotein antibody-associated disease. Lancet Neurol. 20(9), 762\u2013772 (2021).","journal-title":"Lancet Neurol"},{"issue":"134","key":"21592_CR14","first-page":"1","volume":"15","author":"S Jarius","year":"2018","unstructured":"Jarius, S. et al. MOG encephalomyelitis\u202f: international recommendations on diagnosis and antibody testing. J. Neuroinflamm. 15(134), 1\u201310 (2018).","journal-title":"J. Neuroinflamm."},{"key":"21592_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/FNEUR.2022.947630","author":"GS Manzano","year":"2022","unstructured":"Manzano, G. S. et al. Positive predictive value of MOG-IgG for clinically defined MOG-AD within a real-world cohort. Front. Neurol. https:\/\/doi.org\/10.3389\/FNEUR.2022.947630 (2022).","journal-title":"Front. Neurol."},{"issue":"6","key":"21592_CR16","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1001\/jamaneurol.2021.0912","volume":"78","author":"E Sechi","year":"2021","unstructured":"Sechi, E. et al. Positive predictive value of myelin oligodendrocyte glycoprotein autoantibody testing. JAMA Neurol. 78(6), 741\u2013746. https:\/\/doi.org\/10.1001\/jamaneurol.2021.0912 (2021).","journal-title":"JAMA Neurol."},{"key":"21592_CR17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/J.NEURO.2016.03.020","volume":"61","author":"KA McKay","year":"2017","unstructured":"McKay, K. A., Jahanfar, S., Duggan, T., Tkachuk, S. & Tremlett, H. Factors associated with onset, relapses or progression in multiple sclerosis: a systematic review. Neurotoxicology 61, 189\u2013212. https:\/\/doi.org\/10.1016\/J.NEURO.2016.03.020 (2017).","journal-title":"Neurotoxicology"},{"issue":"3","key":"21592_CR18","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s13679-020-00397-8","volume":"9","author":"C Tsigalou","year":"2020","unstructured":"Tsigalou, C., Vallianou, N. & Dalamaga, M. Autoantibody production in obesity: is there evidence for a link between obesity and autoimmunity?. Curr. Obes. Rep. 9(3), 245\u2013254. https:\/\/doi.org\/10.1007\/s13679-020-00397-8 (2020).","journal-title":"Curr. Obes. Rep."},{"issue":"9","key":"21592_CR19","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","volume":"13","author":"M Versini","year":"2014","unstructured":"Versini, M., Jeandel, P. Y., Rosenthal, E. & Shoenfeld, Y. Obesity in autoimmune diseases: not a passive bystander. Autoimmun. Rev. 13(9), 981\u20131000. https:\/\/doi.org\/10.1016\/j.autrev.2014.07.001 (2014).","journal-title":"Autoimmun. Rev."},{"issue":"9","key":"21592_CR20","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1177\/1352458512436596","volume":"18","author":"AK Hedstr\u00f6m","year":"2012","unstructured":"Hedstr\u00f6m, A. K., Olsson, T. & Alfredsson, L. High body mass index before age 20 is associated with increased risk for multiple sclerosis in both men and women. Mult. Scler. J. 18(9), 1334\u20131336. https:\/\/doi.org\/10.1177\/1352458512436596 (2012).","journal-title":"Mult. Scler. J."},{"key":"21592_CR21","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1212\/WNL.0000000000000203","volume":"82","author":"AK Hedstr\u00f6m","year":"2014","unstructured":"Hedstr\u00f6m, A. K. et al. Interaction between adolescent obesity and HLA risk genes in the etiology of multiple sclerosis. Neurology 82, 865\u2013872 (2014).","journal-title":"Neurology"}],"updated-by":[{"DOI":"10.1038\/s41598-023-30115-y","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T00:00:00Z","timestamp":1676851200000}}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21592-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21592-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21592-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,20]],"date-time":"2023-02-20T11:16:23Z","timestamp":1676891783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-21592-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,9]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["21592"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-21592-8","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41598-023-30115-y","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,9]]},"assertion":[{"value":"30 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 February 2023","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41598-023-30115-y","URL":"https:\/\/doi.org\/10.1038\/s41598-023-30115-y","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"21312"}}